Mode
Text Size
Log in / Sign up

Virtual reality training improves global cognitive function and short-term memory in Alzheimer's disease patientsVirtual Reality Training Improves Memory in Alzheimer's Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider virtual reality training for improving short-term memory and global cognition in Alzheimer's disease patients.

This meta-analysis synthesized data from 11 randomized controlled trials to evaluate the impact of virtual reality-based training on various cognitive and functional outcomes in patients with Alzheimer's disease. The analysis focused on global cognitive performance, specific cognitive domains, psychosocial function, and physical capabilities.

The synthesis indicates that virtual reality interventions resulted in significantly better global cognitive function (SMD = 0.44; 95%CI 0.21-0.68) and short-term memory (SMD = 0.62; 95%CI 0.25-0.99) compared to controls. Conversely, no significant improvements were observed in executive function, spatial memory, activities of daily living, quality of life, balance and coordination, fear of falling, risk of falls, or depression levels.

The authors acknowledge that the evidence for efficacy in patients with Alzheimer's disease is weak and limited across many indicators due to small sample sizes. While virtual reality shows promise for specific cognitive domains like short-term memory, its impact on broader functional outcomes remains unproven. Clinicians may consider it as a targeted intervention for memory, but results should be interpreted with caution given the current limitations in evidence strength.

How this fits prior evidence

This meta-analysis extends prior findings regarding non-pharmacological interventions for Alzheimer's disease. While previous reports indicated that mindfulness-based exercise shows favorable signals for patients with Alzheimer's, this study specifically identifies virtual reality as a potential tool for improving global cognitive function and short-term memory. It addresses a gap in understanding specific digital interventions compared to broader lifestyle modifications.

A review of 11 randomized controlled trials looked at how virtual reality (VR) based training affects people diagnosed with Alzheimer's disease. The researchers compared patients using VR programs against a control group to see if the technology helped with different types of mental and physical tasks.

The study found that participants who used virtual reality showed significantly better global cognitive function and short-term memory than those in the control group. However, the research did not find significant improvements in other areas, such as executive function, spatial memory, balance, or quality of life.

It is important to note that the evidence for these findings is currently considered weak and limited because of a small sample size across the studies reviewed. While some cognitive benefits were seen, many other factors like depression levels and risk of falls did not show change. Patients should talk to their doctors about how these specific technologies might fit into their personal care plans.

What this means for you:
Virtual reality training may improve short-term memory in Alzheimer's patients, but evidence remains limited.

Common questions

Can virtual reality help with memory loss in Alzheimer's?

The study found that patients using virtual reality based training showed significantly better short-term memory compared to those who did not use it. While this is a positive finding, the researchers noted that the overall evidence for these improvements is currently weak and limited due to small sample sizes.

Does virtual reality improve other symptoms of Alzheimer's?

The study found no significant improvements in several other areas. These included executive function, spatial memory, balance, coordination, fear of falling, and depression levels. Because the evidence is limited, these specific areas were not shown to improve with the training.

Is virtual reality safe for people with Alzheimer's?

The study did not report any specific adverse events or safety concerns regarding the use of virtual reality. However, because the evidence is still considered weak and limited by small sample sizes, you should consult a healthcare provider before starting new treatments.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND AND OBJECTIVES: Prior meta-analyses have suggested that training utilizing virtual reality (VR) serves as a secure and effective intervention for elderly individuals experiencing mild cognitive impairment (MCI). Nevertheless, the effectiveness of such interventions appears to differ among various populations and cognitive domains. Furthermore, there remains a significant gap in understanding the effectiveness of VR-based training, specifically among individuals diagnosed with Alzheimer's disease (AD). METHODS: The researchers conducted a comprehensive search of databases, including Web of Science, PubMed, Cochrane Library, and EMBASE up until July 1, 2025, focusing on randomized controlled trials that investigated VR-based training in patients diagnosed with AD. The outcomes measured were categorized and analyzed separately, encompassing overall cognitive performance, distinct cognitive domains, psychosocial function, physical capabilities, and the execution of daily living activities within the context of AD trials. RESULTS: Of the 265 publications identified, 11 (4.15%) randomized controlled trials (RCTs) eventually met all eligibility criteria. Those who received VR-based training showed significantly better global cognitive function [SMD (95%CI) = 0.44 (0.21-0.68)] and Short-term memory [SMD (95%CI) = 0.62 (0.25-0.99)] than the controls. However, no significant improvements were observed in areas such as executive function, spatial memory, activities of daily living, quality of life, balance and coordination, fear of falling, risk of falls, and depression levels. CONCLUSION: VR-based interventions demonstrated beneficial effects on global cognitive function and short-term memory in AD populations. Due to the small sample size, the current research on evidence for efficacy in people with AD is weak and limited in many indicators.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.